AstraZeneca Pharma India Ltd Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

8,550.00 -73.00 (-0.85%)Updated : 06 Feb 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	1,598.73	1,108.91	894.34	736.24
Other Net	8.69	1.34	0.21	0.46
Diluted Weighted Average Shares	2.50	2.50	2.50	2.50
Gain( Loss)on Saleof Assets	0.32	0.03	2.49	2.82
Depreciation/ Amortization	39.99	14.94	16.26	16.95
Operating Income	117.56	186.62	108.63	69.36
Net Income	115.74	161.51	99.29	61.60
Income Availableto Com Excl Extra Ord	115.74	161.51	99.29	61.60
Other Operating Expenses Total	9.51	12.07	9.89	10.09
Net Income Before Taxes	156.36	219.54	134.10	83.04
Net Income After Taxes	115.74	161.51	99.29	61.60
Income Availableto Com Incl Extra Ord	115.74	161.51	99.29	61.60
Costof Revenue Total	1,005.88	678.13	430.80	365.56
Gross Profit	710.41	617.40	572.17	440.04
Interest Inc( Exp) Net- Non- Op Total	29.79	31.55	22.77	10.40
Unusual Expense( Income)	97.25	-15.19	40.23	-
Diluted Net Income	115.74	161.51	99.29	61.60
DPS- Common Stock Primary Issue	32.00	24.00	16.00	10.00
Provisionfor Income Taxes	40.62	58.03	34.81	21.44
period Type	-	-	-	-
Net Income Before Extra Items	115.74	161.51	99.29	61.60
Total Revenue	1,716.29	1,295.53	1,002.97	805.60
period Length	12.00	12.00	12.00	12.00
Revenue	1,716.29	1,295.53	1,002.97	805.60
Selling/ General/ Admin Expenses Total	446.10	418.96	397.16	343.64
Diluted Normalized EPS	75.00	60.13	50.89	23.80
Diluted EPS Excluding Extra Ord Items	46.30	64.60	39.72	24.64